Skip to main content
SpringerLink
Log in

Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Whyte MP (2016) Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246

    Article  PubMed  CAS  Google Scholar 

  2. Whyte MP (2017) Hypophosphatasia: An overview for 2017. Bone

  3. Bowden SA, Adler BH (2017) Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporos Int

  4. STRENSIQ™ (asfotase alfa) [prescribing information]. Cheshire, CT: Alexion Pharmaceuticals, Inc; 2015. Available from: http://www.alexion.com/Documents/Strensiq_USPI.aspx

  5. Millán JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299–306

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Department of Pediatrics, Nationwide Children’s Hospital/The Ohio State University College of Medicine, 700 Children’s Drive, Columbus, OH, 43205, USA

    S. A. Bowden

  2. Department of Radiology, Nationwide Children’s Hospital/The Ohio State University College of Medicine, Columbus, OH, 43205, USA

    B. H. Adler

Authors
  1. S. A. Bowden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. H. Adler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. A. Bowden.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bowden, S.A., Adler, B.H. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia. Osteoporos Int 29, 2155–2156 (2018). https://doi.org/10.1007/s00198-018-4613-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-018-4613-7

Keywords

Search

Navigation